2026 medicine Nobel honours three pioneers of studying neurons with light

The 2026 Nobel Prize in Physiology or Medicine was awarded to Karl Deisseroth, Peter Hegemann and Georg Nagel for light-gated ion channels and optogenetics.

It honours a research tool for changing selected cells’ activity with light; it does not mean a flashlight can control an ordinary human brain or cure every brain disorder.

A tool that began with green algae

The Nobel committee announced the joint award on October 5, and AP independently confirmed the recipients and field. The starting point was a light-sensitive protein in a single-celled green alga. Hegemann and Nagel’s work showed how light opens a channel in a cell membrane, allowing charged particles to pass. Introducing such a channel into a neuron can make light a switch for its electrical activity.

From a cell experiment to living animals

The official account describes Deisseroth introducing the gene for a light-sensitive protein into rat neurons in 2005 and inducing signals with light. Work in living mice followed in 2007. These dates identify different stages: demonstrating a method in cells is distinct from studying a circuit in a living animal. Neither date represents the completion of a treatment for people.

Testing causes, rather than only observing activity

Seeing a neuron activate during a behaviour does not establish that it caused that behaviour. Changing the activity of selected cells and comparing the outcome gives researchers a more direct way to test a causal relationship. That is an important contribution of optogenetics. The conclusions still depend on which cells, animals and circuits were studied, rather than applying automatically to every brain.

Clinical applications need their own evidence

The method requires cells to produce a light-sensitive protein and requires light to reach the relevant tissue. Shining ordinary light at someone’s head is a different action. Clinical applications, including attempts to restore vision, are being investigated, but the award itself is neither treatment approval nor a guarantee of benefit. The committee’s background account and individual clinical-trial results are the next checks. Safety, durability and eligible patients must be assessed for each treatment.

Primary source and independent checks

Primary source and official explanation: Nobel Prize

Primary source and official explanation: Nobel Prize

Independent reporting check: Associated Press

Read in other languages

한국어 · English · Español · 日本語 · Tiếng Việt